Scientists repair damage from heart attack using adult bone marrow stem cells in mice

March 29, 2001

BETHESDA, MD - Surprising new research shows it is possible to rebuild heart-attack-damaged hearts with adult stem cells from bone marrow. Scientists at the National Institutes of Health (NIH) and New York Medical College, Valhalla, NY, demonstrated for the first time that adult stem cells isolated from mouse bone marrow could become functioning heart muscle cells when injected into a damaged mouse heart. More important for future clinical application in humans, the new cells at least partially restore the heart's ability to pump blood.

The research team, led by Donald Orlic, Ph.D., a staff scientist in the genetics and molecular biology branch of the Division of Intramural Research at the National Human Genome Research Institute (NHGRI), and Piero Anversa, M.D., professor of medicine and director of the Cardiovascular Research Institute at New York Medical College, reported their results in the April 4, 2001, issue of NATURE.

"This study offers hope that we might one day be able to actually reverse the damage caused by a heart attack," says NHGRI Director Francis S. Collins, M.D., Ph.D. "The apparent ability of stem cells in the bone marrow of adult animals to rebuild the heart reveals nature's remarkably flexible response to disease."

"Our results indicate the great potential of adult stem cells to differentiate into other cell types and repair a damaged organ, a property commonly attributed to embryonic stem cells," Anversa says. "This may allow us to utilize a patient's own stem cells as a new therapeutic option."

Typically, stem cells can be found in various tissues, such as muscle and skin, where they continuously replenish lost cells. Bone marrow stem cells usually produce blood elements, such as red and white blood cells. A growing body of research, however, suggests that stem cells - both embryonic and adult - retain the ability to differentiate into a wider array of body tissues that may be used as a cellular therapy to treat disease.

Heart attacks provide an important target for this treatment because they are a leading cause of death. About 1.1 million Americans will suffer a heart attack this year; some 450,000 will die. A heart attack occurs when the coronary arteries that carry blood to the heart muscles become blocked. The interruption in the blood supply suffocates the heart muscle cells below the blockage, substantially reducing the heart's ability to pump blood. Typically, if more than 40 percent of the left ventricle (the main pumping chamber of the heart) is damaged, the patient ultimately dies.

In their search for a way to reverse the damage, the team began by isolating bone marrow stem cells from male mice. The isolated stem cells carried a newly inserted gene that produces green fluorescent protein, a marker that enabled the researchers to identify the transplanted cells. In addition, the researchers decided to transplant stem cells from male mice into female hearts so they could show definitively that any new heart muscle had come from donor cells.

The researchers then gave the female mice a heart attack by tying a suture around a coronary artery commonly blocked in human disease. A short time later, they injected the labeled stem cells into the heart muscle next to the damaged tissue. Remarkably, over the next seven to 11 days, the stem cells began to multiply and transform themselves into heart muscle cells and migrated into the damaged area. After an average of nine days, the newly formed heart muscle cells occupied 68 percent of the damaged portion of the heart. In addition, the stem cells also began producing smooth muscle cells and endothelial cells that organized themselves into new blood vessels.

"Initially, I thought if there was a little regeneration, some heart muscle cells forming, then that would be considered successful," NHGRI's Orlic says. "Instead, our expectations were far exceeded in terms of seeing not just heart muscle cells, but blood vessels and functional measurements showing that the repair actually improved cardiac output. It was a wonderful surprise and went far beyond our expectations."

Still, the treatment only worked in 12 of 30 mice, about 40 percent. That may be due to the difficulty of injecting the stem cells into a heart that beats on the average of 600 times per minute. New research is already underway to resolve these questions.

New York Medical College's Anversa predicts that if follow-up studies go well, clinical trials in human patients could begin in three years. "The restoration in the heart's ability to pump blood could well be clinically significant," he says.

In addition to Orlic and Anversa, co-authors of the study include: Stacie M. Anderson and David M. Bodine of NHGRI; Jan Kajstura, Stefano Chimenti, Igor Jakoniuk, Baosheng Li, Bernardo Nadal-Ginard, Annarosa Leri of New York Medical College and James Pickel and Ronald McKay of the National Institute of Neurological Disorders and Stroke, NIH.

For additional information, including a graphic showing the procedure and high-resolution images of the regenerating cells, go to http://www.nhgri.nih. gov/NEWS/news.html
Embargoed: NATURE has changed the embargo to 5 p.m. Eastern, Friday, March 30, 2001, so journalists can include this information with a report on similar research in NATURE Medicine.

For additional information, contact:
NHGRI: Geoff Spencer, 301-402-0911, New York Medical College: Marjorie Roberts, 914-594-4536

NIH/National Institute on Drug Abuse

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to